Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae-Reference-Cited by-同舟云学术

Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae

Published:2002-07 Issue:3-4 Volume:86 Page:221-228
ISSN:0165-2427
Container-title:Veterinary Immunology and Immunopathology
language:en
Short-container-title:Veterinary Immunology and Immunopathology

Author:

Appleyard G.D.,Furesz S.E.,Wilkie B.N.

Publisher

Elsevier BV

Subject

General Veterinary,Immunology

Reference19 articles.

1. Characterization of porcine CD5 and CD5+ B-cells;Appleyard;Clin. Exp. Immunol.,1998

2. Bomford, R., 1986. Mineral gel adjuvants; why has it taken so long to find an alternative. In: Bell, R., Torrigiani, G. (Eds.), Progress Towards Better Vaccines. Oxford Medical Publications, New York, pp. 176–183.

3. CD5+ B-lymphocytes are the main source of antibodies reactive with non-parasite antigens in Trypanosoma congolense-infected cattle;Buza;Immunology,1997

4. Humoral antibody response and protective immunity in swine following immunization with the 104 kilodalton hemolysin of Actinobacillus pleuropneumoniae;Devenish;Infect. Immun.,1990

5. Immune responses to lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs;Fenwick;Infect. Immun.,1986

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between trace elements and T-cell immunity during early-life health in pigs;Science China Life Sciences;2023-06-06

2. Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune Cells of a Porcine Model for Laron Syndrome;Biomolecules;2023-03-26

3. The FlagT4G Vaccine Confers a Strong and Regulated Immunity and Early Virological Protection against Classical Swine Fever;Viruses;2022-09-02

4. Actinobacillus;Pathogenesis of Bacterial Infections in Animals;2022-08-19

5. The new emerging ovine pestivirus can infect pigs and confers strong protection against classical swine fever virus;Transboundary and Emerging Diseases;2021-05-05